The Lancet HIV

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

The Lancet HIV is a journal published by Elsevier BV in Netherlands. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 6,300 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
2405-4704 · 2352-3018
Country
Netherlands
Access
Not open access / not declared
Declared publication charge
6,300 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2015-01-01
  • PUBMED · 2014-11-01
Indexing
MEDLINE · PUBMED
APC
6,300 USD
Declared review time (DOAJ)
—
Actual review time (measured)
71 days received→accepted — computed from PubMed (n=67)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

2037

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

119

i10-index

766

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2027
Level 2 — top tier (~20% of the field's channels)
Open references deposited at Crossref
72%
ORCID iDs in current deposits
2%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101645355
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • HIV/AIDS Research and Interventions
  • HIV/AIDS Research and Interventions
  • HIV, Drug Use, Sexual Risk
  • HIV, Drug Use, Sexual Risk
  • HIV/AIDS drug development and treatment
  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • HIV Research and Treatment
Show all subjects (50)
  • HIV-related health complications and treatments
  • HIV-related health complications and treatments
  • Adolescent Sexual and Reproductive Health
  • Adolescent Sexual and Reproductive Health
  • HIV/AIDS Impact and Responses
  • HIV/AIDS Impact and Responses
  • Sex work and related issues
  • Sex work and related issues
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Global Maternal and Child Health
  • Global Maternal and Child Health
  • LGBTQ Health, Identity, and Policy
  • LGBTQ Health, Identity, and Policy
  • Global Public Health Policies and Epidemiology
  • Global Public Health Policies and Epidemiology
  • Tuberculosis Research and Epidemiology
  • Tuberculosis Research and Epidemiology
  • Hepatitis C virus research
  • Viral-associated cancers and disorders
  • Viral-associated cancers and disorders
  • Hepatitis C virus research
  • Migration, Health and Trauma
  • Migration, Health and Trauma
  • Poverty, Education, and Child Welfare
  • Poverty, Education, and Child Welfare
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies
  • African Sexualities and LGBTQ+ Issues
  • African Sexualities and LGBTQ+ Issues
  • Reproductive tract infections research
  • Mobile Health and mHealth Applications
  • Reproductive tract infections research
  • Hepatitis B Virus Studies
  • Hepatitis B Virus Studies
  • Mobile Health and mHealth Applications
  • Syphilis Diagnosis and Treatment
  • Syphilis Diagnosis and Treatment
  • Cervical Cancer and HPV Research
  • Vaccine Coverage and Hesitancy
  • Cervical Cancer and HPV Research
  • Vaccine Coverage and Hesitancy

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: